相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease
Andrea Haake et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines
Cristobal de los Rios et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The impact of dementia on hospital outcomes for elderly patients with sepsis: A population-based study
Carmen Bouza et al.
PLOS ONE (2019)
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy
Eva Ramos et al.
MOLECULES (2019)
Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines
Manuela Bartolini et al.
CHEMICAL RECORD (2019)
Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy
Youssef Dgachi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Alzheimer's Disease, the One-Molecule, One-Target Paradigm, and the Multitarget Directed Ligand Approach
Maria Jesus Oset-Gasque et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy
Mourad Chioua et al.
CHEMISTRYSELECT (2018)
New (benz) imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease
Houssem Boulebd et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration
Eva Ramos et al.
FUTURE MEDICINAL CHEMISTRY (2017)
5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino) octyl)-5H-indolo[2,3-b] quinolin-11-amine: a highly potent human cholinesterase inhibitor
Li Wang et al.
MEDCHEMCOMM (2017)
Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines
Alejandro Romero et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno-PyranoTacrines
Maria Jesus Oset-Gasque et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators
Mohamed Benchekroun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2015)
Novel Tacrine-Grafted Ugi Adducts as Multipotent Anti-Alzheimer Drugs: A Synthetic Renewal in Tacrine-Ferulic Acid Hybrids
Mohamed Benchekroun et al.
CHEMMEDCHEM (2015)
Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease
Rafael Leon et al.
MEDICINAL RESEARCH REVIEWS (2013)
Chemistry and Biology Of Multicomponent Reactions
Alexander Domling et al.
CHEMICAL REVIEWS (2012)
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
Abdelouahid Samadi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study
A. Marengoni et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
Abdelouahid Samadi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Recent advances in multicomponent reactions for diversity-oriented synthesis
James E. Biggs-Houck et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Impact of Dementia on Hospitalization
Ricardo Guijarro et al.
NEUROEPIDEMIOLOGY (2010)
Dementia in the acute hospital: prospective cohort study of prevalence and mortality
Elizabeth L. Sampson et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Recent Advances in the Friedlander Reaction
Jose Marco-Contelles et al.
CHEMICAL REVIEWS (2009)
Tacripyrines, the First Tacrine-Dihydropyridine Hybrids, as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease
Jose Marco-Contelles et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease
Jiri Patocka et al.
CURRENT DRUG METABOLISM (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Multi-target-directed drug design strategy: From a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease
Maria Laura Bolognesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Dimeric and hybrid anti-Alzheimer drug candidates
D Munoz-Torrero et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Rational approach to discover multipotent anti-Alzheimer drugs
M Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay
A Dávalos et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2004)
Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease
DM Du et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe
BX Ou et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
分享论文
